Foray Bioscience Secures $3M in Seed Funding to Expand Plant Cell Culture Platform

Key Highlights:

  • Foray Bioscience raises $3M in seed funding led by ReGen Ventures.

  • Funding to expand predictive plant cell culture platform and launch product development.

  • Boston-based team expansion and new leadership appointments.

  • Focus on plant conservation, restoration, and production using plant cell culture.

Source (Business Wire)

Notable Quotes:

“We believe plant cell culture is a critical and underutilized tool for plant conservation, restoration, and production. With Foray’s technology, our goal is to make biomanufacturing accessible across species and applications by significantly reducing the barriers to entry.”

Dr. Ashley Beckwith, Founder and CEO at Foray

“Foray is reimagining the manufacturing of plant products. The company’s versatile approach will build much-needed resiliency into our plant supply chains and solve for persistent seed deficits in the reforestation sector.”

Parker Hughes, Principal at ReGen Ventures and Board Member at Foray

Our Take:

Foray Bioscience's recent $3 million seed funding round marks a significant milestone in the advancement of biomanufacturing technology. By leveraging plant cell culture, Foray is poised to address critical issues in plant conservation and production. The company's innovative approach, driven by a predictive database and advanced optimization strategies, promises to make plant cell culture more accessible and efficient. This development is particularly timely given the growing environmental challenges and the urgent need for sustainable solutions in plant-sourced goods. With strategic investments and a strong leadership team, Foray is well-positioned to lead the way in sustainable biomanufacturing and contribute meaningfully to the restoration of natural ecosystems.